Authors:
WETZEL H
GRUNDER G
HILLERT A
PHILIPP M
GATTAZ WF
SAUER H
ADLER G
SCHRODER J
REIN W
BENKERT O
Citation: H. Wetzel et al., AMISULPRIDE VERSUS FLUPENTIXOL IN SCHIZOPHRENIA WITH PREDOMINANTLY POSITIVE SYMPTOMATOLOGY - A DOUBLE-BLIND CONTROLLED-STUDY COMPARING A SELECTIVE D-2-LIKE ANTAGONIST TO A MIXED D-1- D-2-LIKE ANTAGONIST/, Psychopharmacology, 137(3), 1998, pp. 223-232
Citation: G. Grunder, TIME-COURSE OF 5-HT2A RECEPTOR OCCUPANCY IN THE HUMAN BRAIN AFTER A SINGLE ORAL DOSE OF THE PUTATIVE ANTIPSYCHOTIC DRUG MDL-100,907 MEASURED BY POSITRON-EMISSION-TOMOGRAPHY (VOL 17, PG 175, 1997), Neuropsychopharmacology, 19(2), 1998, pp. 160-160
Citation: E. Davids et al., PHARMACOTHERAPY OF PSYCHIATRIC-DISORDER D URING PREGNANCY AND BREAST-FEEDING, Fortschritte der Neurologie, Psychiatrie, 66(5), 1998, pp. 207-224
Authors:
WONG DF
GJEDDE A
REITH J
GRUNDER G
SZYMANSKI S
YOKOI F
HONG C
NESTADT G
NEUFELD K
PEARLSON G
TUNE L
ANGRIST B
Citation: Df. Wong et al., MULTIPLE LINES OF EVIDENCE FOR DOPAMINE DYSFUNCTION IN PSYCHOSIS BY IMAGING, Schizophrenia research, 24(1-2), 1997, pp. 183-183
Authors:
GRUNDER G
YOKOI F
OFFORD SJ
RAVERT HT
DANNALS RF
SALZMANN JK
SZYMANSKI S
WILSON PD
HOWARD DR
WONG DF
Citation: G. Grunder et al., TIME-COURSE OF 5-HT2A RECEPTOR OCCUPANCY IN THE HUMAN BRAIN AFTER A SINGLE ORAL DOSE OF THE PUTATIVE ANTIPSYCHOTIC DRUG MDL-100,907 MEASURED BY POSITRON EMISSION TOMOGRAPHY, Neuropsychopharmacology, 17(3), 1997, pp. 175-185
Citation: O. Benkert et al., IS THERE AN ADVANTAGE TO VENLAFAXINE IN COMPARISON WITH OTHER ANTIDEPRESSANTS, Human psychopharmacology, 12(1), 1997, pp. 53-64
Authors:
WONG DF
YOKOI F
GRUNDER G
HONG C
SZYMANSKI S
DOGUN A
NESTADT G
NEUFELD K
GJEDDE A
Citation: Df. Wong et al., THE EFFECT OF INTRASYNAPTIC DOPAMINE RELEASE ON MEASURING B-MAX AND B-MAX K(D) IN SCHIZOPHRENIA BY PET/, The Journal of nuclear medicine, 38(5), 1997, pp. 32-32
Authors:
GRUNDER G
MULLER M
SCHLEGEL S
WETZEL H
SCHLOSSER R
ANDREAS J
EISSNER D
BENKERT O
Citation: G. Grunder et al., HIGH-DEGREE OF STRIATAL D2-LIKE DOPAMINE-RECEPTOR OCCUPANCY BY THE SIGMA-LIGAND EMD-57445, A PUTATIVE ATYPICAL ANTIPSYCHOTIC, The Journal of nuclear medicine, 38(5), 1997, pp. 398-398
Authors:
YOKOI F
SZYMANSKI S
OFFORD SJ
GRUNDER G
DOGAN AS
RAVERT HT
DANNALS RF
LONDON ED
GJEDDE A
WONG DF
Citation: F. Yokoi et al., EFFECT OF CHOLINESTERASE-INHIBITORS ON BINDING TO NICOTINIC ACETYLCHOLINE-RECEPTORS IN HUMAN BRAIN - A PET COMPARISON, The Journal of nuclear medicine, 38(5), 1997, pp. 1215-1215
Citation: G. Grunder et al., SUBCHRONIC ANTIDEPRESSANT TREATMENT WITH VENLAFAXINE OR IMIPRAMINE AND EFFECTS ON BLOOD-PRESSURE AND HEART-RATE - ASSESSMENT BY AUTOMATIC 24-HOUR MONITORING, Pharmacopsychiatry, 29(2), 1996, pp. 72-78
Authors:
WONG DF
GRUNDER G
YOKOI F
SZYMANSKI S
RAVERT HT
MATHEWS WB
MUSACHIO KL
SCHEFFEL U
DANNALS RF
Citation: Df. Wong et al., IMAGING HUMAN CEREBRAL SEROTONIN 5-HT2A RECEPTORS WITH C-11 MDL-100907, The Journal of nuclear medicine, 37(5), 1996, pp. 438-438
Authors:
GRUNDER G
YOKOI F
OFFORD SJ
SALZMANN JK
KRASENBAUM DN
SZYMANSKI S
RAVERT HT
DANNALS RF
WONG DF
Citation: G. Grunder et al., HUMAN 5-HT1A RECEPTOR OCCUPANCY AFTER A SINGLE-DOSE OF A PUTATIVE ATYPICAL ANTIPSYCHOTIC MDL-100907, The Journal of nuclear medicine, 37(5), 1996, pp. 439-439
Citation: O. Benkert et al., A RANDOMIZED, DOUBLE-BLIND COMPARISON OF A RAPIDLY ESCALATING DOSE OFVENLAFAXINE AND IMIPRAMINE IN INPATIENTS WITH MAJOR DEPRESSION AND MELANCHOLIA, Journal of Psychiatric Research, 30(6), 1996, pp. 441-451
Authors:
GRUNDER G
WETZEL H
HILLERT A
JOCHUM E
HIEMKE C
BENKERT O
Citation: G. Grunder et al., THE NEUROENDOCRINOLOGICAL PROFILE OF ROXINDOLE, A DOPAMINE AUTORECEPTOR AGONIST, IN SCHIZOPHRENIC-PATIENTS, Psychopharmacology, 117(4), 1995, pp. 472-478
Citation: H. Wetzel et al., ROXINDOLE, A DOPAMINE AUTORECEPTOR AGONIST, IN THE TREATMENT OF POSITIVE AND NEGATIVE SCHIZOPHRENIC SYMPTOMS, The American journal of psychiatry, 151(10), 1994, pp. 1499-1502